John Öhrvik
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 16
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 8
- Diabetes Treatment and Management 7
- Rheumatology top 1%
-
- Cardiovascular Function and Risk Factors 12
- Surgery top 5%
- Lipoproteins and Cardiovascular Health 6
- Hematology top 5%
-
- Metabolism, Diabetes, and Cancer 10
-
- Adipokines, Inflammation, and Metabolic Diseases 5
-
- Health Systems, Economic Evaluations, Quality of Life 3
- Co-authors
- David E.L. WilckenLars BrudinLars BrattströmLars RydénHooshang MajdiK. MalmbergAnders HamstenGöran Nilsson
- Partner nations
- SwedenItalyUnited Kingdom
In The Last Decade
John Öhrvik
64 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Endocrinology, Diabetes and Metabolism 865
- Rheumatology 619
- Cardiology and Cardiovascular Medicine 858
- Surgery 697
- Hematology 164
Countries citing papers authored by John Öhrvik
This map shows the geographic impact of John Öhrvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Öhrvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Öhrvik more than expected).
Fields of papers citing papers by John Öhrvik
This network shows the impact of papers produced by John Öhrvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Öhrvik. The network helps show where John Öhrvik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Öhrvik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2019 | 33 | |
| 3 | 2017 | 86 | |
| 4 | 2014 | 15 | |
| 5 | 2012 | 23 | |
| 6 | 2011 | 14 | |
| 7 | 2011 | 34 | |
| 8 | 2010 | 15 | |
| 9 | 2010 | 41 | |
| 10 | 2009 | 58 | |
| 11 | 2009 | 46 | |
| 12 | 2009 | 7 | |
| 13 | 2009 | 15 | |
| 14 | 2009 | 26 | |
| 15 | 2009 | 13 | |
| 16 | 2008 | 6 | |
| 17 | 2008 | 34 | |
| 18 | 2008 | 105 | |
| 19 | 2006 | 128 | |
| 20 | 2006 | 2 |
About John Öhrvik
John Öhrvik is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Applied Psychology, Pharmacy and Immunology and Allergy, having authored 65 papers that have together received 2.9k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers), Cardiovascular Function and Risk Factors (12 papers), Metabolism, Diabetes, and Cancer (10 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (8 papers), Diabetes Treatment and Management (7 papers), Lipoproteins and Cardiovascular Health (6 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (865 citations), Rheumatology (619 citations), Cardiology and Cardiovascular Medicine (858 citations), Surgery (697 citations) and Hematology (164 citations). John Öhrvik has collaborated with scholars based in Sweden, Italy and United Kingdom. Frequent co-authors include David E.L. Wilcken, Lars Brudin, Lars Brattström, Lars Rydén, Hooshang Majdi, K. Malmberg, Anders Hamsten, Göran Nilsson, Matteo Anselmino and Anna Norhammar. Their work appears in journals such as European Heart Journal, Diabetes Care, BMJ Open, Metabolic Syndrome and Related Disorders and Diabetes and Vascular Disease Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.